Safety and Efficacy of XP200 Radiofrequency Treatment of Wrinkles

NCT ID: NCT01795417

Last Updated: 2013-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-08-31

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the wrinkle-reducing effects of 3.25-MHz radiofrequency (RF) energy delivered in 4 weekly applications to human periorbital skin area by grating pre- and 90-days post treatment photographs on the Fitzpatrick Wrinkle Severity Scale (FWSS) by three blinded evaluators.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periorbital Wrinkles

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

wrinkles rhytids periorbital

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

XP200 device RF treatments

Every subject in the study will undergo 4 treatments and will be followed up for 6 months with photoraphic 3 evaluations: before treatment, 3 and 6 months follow-up. Photographs will be scored on a Fitzpatrick scale by 3 blinded evaluators.

Group Type EXPERIMENTAL

RF XP200

Intervention Type DEVICE

Four weekly non-invasive periorbital wrinkles treatment with RF XP200 device

XP200 RF device

Intervention Type DEVICE

4 RF treatments of periorbital region on one side of the face

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RF XP200

Four weekly non-invasive periorbital wrinkles treatment with RF XP200 device

Intervention Type DEVICE

XP200 RF device

4 RF treatments of periorbital region on one side of the face

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 35-60 years old
* periorbital wrinkles
Minimum Eligible Age

35 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

BTL Industries Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Georgi Petkov

Role: STUDY_DIRECTOR

BTL Industries Ltd.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

XP200 3.25 MHZ RF

Identifier Type: -

Identifier Source: org_study_id